Oncotarget is a medical journal in which peer-review is done after a week and handles research papers covering all aspects of oncology. The Oncotarget journal was first established in the year 2010 after which it was published by impact journals. The editing of the Oncotarget journal is done by its two chief editors: Mikhail Blagosklonny and Andrei v. Gudkov. Oncotarget is a free to access journal that has covers many disciplines.
The issues by the Oncotarget journal are done weekly. The issues there in can be printed under a special demand. The main aim of Oncotarget journal is to make available the scientific research both widely and rapidly. With this in hand, therefore the researches done by the scientists are maximized, and discoveries can be shared with ease and speed. Oncotarget targets at eliminating the big gap between different fields of biomedical sciences to do away with the differences in specialties and its Twitter.
Oncotarget has a highly experienced leadership on dovepress.com that help researchers in their disciplines participate in the advancing field of science. The chief aim of the n Oncotarget is to achieve a life that is free of diseases. Oncotarget offers free alt-metric reports which enable the real time tracking of articles. This is done in both the traditional and digital media. Above the oncology sections that Oncotarget provides, there are other fields beyond oncology that it covers. They include cardiology, endocrinology, immunology, pharmacology, neuropathology cell together with mol biology. Oncotarget also has many publication ethics including cardiology, immunology, cell and mol biology and neuropathology and learn more about Oncotarget.
Oncotarget editors evaluate data and information presented regarding quality, scientific novelty, merit and presentation regardless of the presenter’s gender, race, religion or citizenship. No other information, agencies or political policies are considered when judging the genuineness of a presented article to be published on the scijournal.org. No information about the manuscript is submitted to any other person other than the reviewers and more information click here.
The information is strictly kept confidential, and no editor is allowed to use unpublished information for any other reason. Peer review is an obligation in Oncotarget. Peer review helps editors to come up with the best solution and comment authors to improve on their manuscript. Any invitation to a reviewer that feels unqualified should be disqualified or the reviewer report to the editors and Oncotarget on Facebook.
More Visit: https://oncotarget.msubmit.net/cgi-bin/main.plex